Affiliation:
1. Mark Greener is a freelance medical writer and journalist
Abstract
The initial excitement inspired by the landmark clinical trials demonstrating the benefits of statins for the prevention of cardiovascular disease was soon dampened by reports of adverse events. Tolerability has remained a controversial topic ever since. However, recent studies suggest that most reported adverse effects of statins can be attributed to the nocebo effect.
Subject
Pharmacology (medical),Pharmacology (nursing)
Reference18 articles.
1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994
2. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
3. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose‐response meta‐analyses;Cai T;BMJ,2021
4. Statin Intolerance and Noncompliance: An Empiric Approach
5. Molecular targets of statins and their potential side effects: Not all the glitter is gold